Related Experiment Video
Updated: Jun 20, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
KLF4 Promotes a KRT13+ Hillock-Like State in Lung Squamous Cell Carcinoma
Luke T Izzo1, Tony Reyes2, Srijan Meesala1
1Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina.
Abstract:
Lung squamous cell carcinoma (LUSC) is a basal-like subtype of lung cancer with limited treatment options. Although prior studies have identified tumor-propagating cell (TPC) states in squamous tumors, further work is needed to elucidate the broader landscape of intratumoral heterogeneity within LUSC. In this study, we employed SOX2-driven mouse models, organoid cultures, and single-cell transcriptomic analyses to uncover cell fate diversity within LUSC, identifying a KRT13+ hillock-like population of slower-dividing tumor cells characterized by immunomodulatory gene expression signatures. The tumor hillock-like state was conserved across multiple animal and human-derived models and was computationally predicted in the majority of human LUSCs, as well as in head and neck and esophageal squamous tumors. Analysis of the cellular origins of tumor hillock-like states indicated that lung club cells give rise to tumors with luminal hillock-like populations, whereas basal-like TPCs transition into basal hillock-like states, resembling lineage plasticity trajectories of the normal lung. Mechanistically, Kruppel-like factor 4 (KLF4) promoted the KRT13+ hillock-like state and contributed to resistance to oxidative stress and platinum-based chemotherapy in vitro. Together, these results provide molecular insights into the lineage plasticity underlying intratumoral heterogeneity within LUSC, offering potential avenues for new therapeutic strategies.
Significance:
KLF4 drives a slow-cycling, KRT13+ hillock-like state that is plastic with basal lineages, promoting intratumoral heterogeneity in lung squamous cell carcinoma and conserved across squamous cancers, with potential implications for treatment resistance. See related commentary by Tong and Ji, p. 4455.
